QR-Code

Clinical Observation of Icotinib Hydrochloride for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified

Background and objective Icotinib is the first self-developed small molecular drug in China for targeted therapy of lung cancer. Compared to the other two commercially available epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, gefitinib and erlotinib, icotinib is similar to them i...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Xi LI, Na QIN, Jinghui WANG, Xinjie YANG, Xinyong ZHANG, Jialin LV, Yuhua WU, Hui ZHANG, Jingying NONG, Quan ZHANG, Shucai ZHANG
Format: Artigo
Sprache:Chinês
Veröffentlicht: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2015-12-01
Schriftenreihe:Chinese Journal of Lung Cancer
Schlagworte:
Lung neoplasms
Icotinib hydrochloride
EGFR mutation
Treatment outcome
Online-Zugang:http://dx.doi.org/10.3779/j.issn.1009-3419.2015.12.04
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge